Phibro Animal Health (PAHC) Cash from Investing Activities (2013 - 2026)

Phibro Animal Health has reported Cash from Investing Activities for 14 years, with the latest figure at -$16.5 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 133.88% year-over-year to -$16.5 million in Q2 2026; TTM through Jun 2026 was -$71.5 million, a 75.25% increase from a year earlier, with the FY2026 full-year figure at -$71.5 million, up 75.25% from the prior year.
• Cash from Investing Activities was -$16.5 million for Q2 2026 at Phibro Animal Health, up from -$16.8 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $1.1 million in Q1 2024, with the low at -$260.5 million in Q4 2024.
• Average Cash from Investing Activities over 5 years is -$27.9 million, with a median of -$15.8 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities soared 102.99% in 2024, then slumped 1715.13% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$9.8 million in 2022, then tumbled by 153.43% to -$24.9 million in 2023, then tumbled by 947.72% to -$260.5 million in 2024, then surged by 93.4% to -$17.2 million in 2025, then climbed by 4.27% to -$16.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$16.5 million (Q2 2026), -$16.8 million (Q1 2026), and -$17.2 million (Q4 2025), per Business Quant data.